Biomolecules (Nov 2022)

PDX-1: A Promising Therapeutic Target to Reverse Diabetes

  • Yanjiao Zhang,
  • Xinyi Fang,
  • Jiahua Wei,
  • Runyu Miao,
  • Haoran Wu,
  • Kaile Ma,
  • Jiaxing Tian

DOI
https://doi.org/10.3390/biom12121785
Journal volume & issue
Vol. 12, no. 12
p. 1785

Abstract

Read online

The pancreatic duodenum homeobox-1 (PDX-1) is a transcription factor encoded by a Hox-like homeodomain gene that plays a crucial role in pancreatic development, β-cell differentiation, and the maintenance of mature β-cell functions. Research on the relationship between PDX-1 and diabetes has gained much attention because of the increasing prevalence of diabetes melitus (DM). Recent studies have shown that the overexpression of PDX-1 regulates pancreatic development and promotes β-cell differentiation and insulin secretion. It also plays a vital role in cell remodeling, gene editing, and drug development. Conversely, the absence of PDX-1 increases susceptibility to DM. Therefore, in this review, we summarized the role of PDX-1 in pancreatic development and the pathogenesis of DM. A better understanding of PDX-1 will deepen our knowledge of the pathophysiology of DM and provide a scientific basis for exploring PDX-1 as a potential target for treating diabetes.

Keywords